Development of a CD123xCD3 bispecific antibody to treat acute myeloid leukemia (AML)

被引：0
|
作者：
Gaudet, Francois
Nemeth, Jennifer F.
McDaid, Ronan
Li, Yingzhe
Harman, Benjamin
Millar, Hillary
Teplyakov, Alexey
Wheeler, John
Luo, Jinquan
Tam, Susan
Wu, Sheng-Jiun
Chen, Emily
Babich, Alexander
Elsayed, Yusri
Attar, Ricardo
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-1492
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1492
引用
收藏
页数：3
相关论文
共 50 条
  • [41] CD123-targeted therapy in acute myeloid leukemia
    Espinoza-Gutarra, Manuel Ricardo
    Green, Steven D.
    Zeidner, Joshua F.
    Konig, Heiko
    EXPERT REVIEW OF HEMATOLOGY, 2021, 14 (06) : 561 - 576
  • [42] Bispecific CD33/CD123 Targeted Chimeric Antigen Receptor T Cells for the Treatment of Acute Myeloid Leukemia
    Boucher, Justin C.
    Shrestha, Bishwas
    Vishwasrao, Paresh
    Leick, Mark B.
    Nhan Tu
    Ghafoor, Tayyebb
    Reid, Kayla M.
    Spitler, Kristen
    Yu, Bin
    Maus, Marcela, V
    Davila, Marco L.
    BLOOD, 2022, 140 : 10275 - 10276
  • [43] A CD3xCD123 bispecific DART for redirecting host T cells to myelogenous leukemia: Preclinical activity and safety in nonhuman primates
    Chichili, Gurunadh R.
    Huang, Ling
    Li, Hua
    Burke, Steve
    He, Leilei
    Tang, Qin
    Jin, Linda
    Gorlatov, Sergey
    Ciccarone, Valentina
    Chen, Francine
    Koenig, Scott
    Shannon, Michele
    Alderson, Ralph
    Moore, Paul A.
    Johnson, Syd
    Bonvini, Ezio
    SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (289)
  • [44] Bispecific CD33/CD123 targeted chimeric antigen receptor T cells for the treatment of acute myeloid leukemia
    Boucher, Justin C.
    Shrestha, Bishwas
    Vishwasrao, Paresh
    Leick, Mark
    Cervantes, Estelle V.
    Ghafoor, Tayyebb
    Reid, Kayla
    Spitler, Kristen
    Yu, Bin
    Betts, Brian C.
    Guevara-Patino, Jose A.
    Maus, Marcela V.
    Davila, Marco L.
    MOLECULAR THERAPY ONCOLYTICS, 2023, 31
  • [45] CD33 directed bispecific antibodies in acute myeloid leukemia
    Clark, Mary C.
    Stein, Anthony
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2020, 33 (04)
  • [46] BIFUNCTIONAL SIRPα-CD123 FUSION ANTIBODY FOR THE ELIMINATION OF ACUTE MYELOID LEUKEMIA STEM CELLS
    Tahk, S.
    Schmitt, S. M.
    Vick, B.
    Augsberger, C.
    Ponce, L. Pascual
    Jeremias, I.
    Wittmann, G.
    Subklewe, M.
    Fenn, N. C.
    Hopfner, K.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2020, 8 : A58 - A58
  • [47] Development of Anti-CD44 Therapeutic Antibody for Acute Myeloid Leukemia
    Zhang Tao
    Qu Hao
    Zhang Li-Yan
    Zhang Yi
    Wang Mei
    Wang Dong-Mei
    He Da-Shui
    Huang Li-Hua
    Zhu Wei-Bin
    Zhang Yu-Guang
    PROGRESS IN BIOCHEMISTRY AND BIOPHYSICS, 2009, 36 (02) : 190 - 197
  • [48] Pre-clinical development of a novel CD3-CD123 bispecific T-cell engager using cross-over dual-variable domain (CODV) format for acute myeloid leukemia (AML) treatment
    Bonnevaux, Helene
    Guerif, Stephane
    Albrecht, Jana
    Jouannot, Erwan
    De Gallier, Thibaud
    Beil, Christian
    Lange, Christian
    Leuschner, Wulf Dirk
    Schneider, Marion
    Lemoine, Cendrine
    Caron, Anne
    Amara, Celine
    Barriere, Cedric
    Siavellis, Justine
    Bardet, Valerie
    Luna, Ernesto
    Agrawal, Pankaj
    Drake, Donald R.
    Rao, Ercole
    Wonerow, Peter
    Carrez, Chantal
    Blanc, Veronique
    Hsu, Karl
    Wiederschain, Dmitri
    Fraenkel, Paula G.
    Virone-Oddos, Angela
    ONCOIMMUNOLOGY, 2021, 10 (01):
  • [49] Selective lysis of acute myeloid leukemia cells by CD34/CD3 bispecific antibody through the activation of γδ T-cells
    Al Agrafi, Faisal
    Gaballa, Ahmed
    Hahn, Paula
    Arruda, Lucas C. M.
    Jaramillo, Adrian C.
    Witsen, Maartje
    Lehmann, Soeren
    Onfelt, Bjoern
    Uhlin, Michael
    Stikvoort, Arwen
    ONCOIMMUNOLOGY, 2024, 13 (01):
  • [50] Adoptive immunotherapy of acute myeloid leukemia (AML) with allogenic CAR t-cells targeting CD123.
    Galetto, Roman
    Lebuhotel, Celine
    Francon, Patricia
    Gouble, Agnes
    Smith, Julianne
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
12345